Chambers & Partners Guide 2020

Chambers & Partners Guide 2020

Jordi Faus, the best lawyer for pharmaceutical law in Spain according to the Chambers & Partners Guide 2020

Chambers and Partners has published the 2020 edition of the Chambers Europe Guide, in which, based on opinions of clients and other lawyers, the leading lawyers and law firms in Europe are identified and classified and Faus & Moliner appears once again as the leading law firm in pharmaceutical law in Spain.

Those consulted by the Chambers & Partners team remark as the main strength of the firm its leadership in regulatory matters on the life sciences industry as well as on pricing and reimbursement. Likewise, they highlight its wide experience on promotional material issues and appreciate the “direct advice” offered by the team, emphasizing its “guidance on the navigation of complex environments”.

Information published by Chambers & Partners on its webpage:

What the team is known for Prestigious Barcelona-based boutique with a stand-out reputation in regulatory issues relating to the life sciences market. Regularly retained by key players from the pharmaceutical and medical devices industries to advise on a range of matters, spanning draft regulations and compliance projects. Also offers strength in pricing and reimbursement matters. Recommended for its prowess in issues relating to promotional material.

Strengths One client appreciates the “straightforward advice” provided by the team, further underlining its “guidance on the navigation of complex environments.”

Work highlights Advised CryoLife on post-closing issues following its acquisition of JOTEC.

Notable practitioners:

Jordi Faus is highly regarded by market commentators and is particularly active on pricing and reimbursement issues for multinational pharmaceutical clients. He also acts on transactions in the life sciences field and the regulation of gene therapies.

Juan Suárez gains recognition from sources for his advice on promotional matters. He also acts on marketing authorisation for medical products and early access matters, as well as pricing and reimbursement.

Xavier Moliner covers regulatory aspects and litigation proceedings related to public procurement. He mainly acts for domestic and multinational pharmaceutical and medical device clients.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información. ACEPTAR

Aviso de cookies